pfizer glp-1 agonist While Lilly and Novo dominate today's $50B+ obesity market, is preparing a killer portfolio to steal the spotlight in 2030s Pharma is pivoting toward preventive

Here, we test whether GLP-1RAs alter alcohols peripheral pharmacokinetics as a potential mechanism of action for their alcohol intake suppressive effects

Within professional research environments, Retatrutide is frequently examined for its role in

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase depression risk, a new review concludes.

A revolutionary 3 strain probiotic

Treatment with GLP1RAs resulted in unaffected or reduced Cmax and delayed tmax of drugs with high solubility and permeability (warfarin, contraceptive pills, acetaminophen), drugs with high solubility and low permeability (angiotensin converting enzyme inhibitors), drugs with low solubility and high permeability (statins) and drugs with low solubility and permeability (digoxin)